Zhengye Biotechnology Holding Limited Zhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited

ZYBT

Rank in Stocks #21002
Zhengye Biotechnology Holding Limited specializes in the creation,... Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
Share Price
$1.50
Last synced: 2026-11-13
Market Cap
$71.09M
Change (1 day)
0.00%
Change (1 year)
-29.91%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Zhengye Biotechnology Holding Limited (ZYBT)

Category

Healthcare
Operating Margin for Zhengye Biotechnology Holding Limited (ZYBT)
Operating Margin as of November 2026 TTM: -68.43%
According to Zhengye Biotechnology Holding Limited's latest financial reports, its current operating margin (TTM) is -68.43%. At the end of 2025 the company had an operating margin of -58.66%.
Operating Margin history for Zhengye Biotechnology Holding Limited from 2021 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -68.43% 16.66%
2025 -58.66% -765.08%
2024 8.82% -58.49%
2023 21.25% -15.97%
2022 25.29% 3.35%
2021 24.47% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
19.69% -100.29%
DE
19.68% -100.29%
DE
13.26% -100.19%
JP
17.08% -100.25%
CH
10.53% -100.15%
IL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Zhengye Biotechnology Holding Limited's operating margin

What is Zhengye Biotechnology Holding Limited's operating margin?

Zhengye Biotechnology Holding Limited's operating margin is -68.43%, as of Nov 2026.

What was Zhengye Biotechnology Holding Limited's operating margin in 2025?

In 2025, Zhengye Biotechnology Holding Limited's operating margin was -58.66%, compared with 8.82% in 2024.

How has Zhengye Biotechnology Holding Limited's operating margin changed since 2021?

From 2021 to 2025, Zhengye Biotechnology Holding Limited's operating margin was highest in 2022 (25.29%) and lowest in 2025 (-58.66%).

How does Zhengye Biotechnology Holding Limited's operating margin compare with similar companies?

Zhengye Biotechnology Holding Limited's operating margin (-68.43%) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with 19.69%.